Logo image of CWAN

CLEARWATER ANALYTICS HDS-A (CWAN) Stock Fundamental Analysis

NYSE:CWAN - New York Stock Exchange, Inc. - US1851231068 - Common Stock - Currency: USD

23.31  -0.35 (-1.48%)

Fundamental Rating

6

Overall CWAN gets a fundamental rating of 6 out of 10. We evaluated CWAN against 283 industry peers in the Software industry. CWAN is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. CWAN is valued quite expensively, but it does show have an excellent growth rating. These ratings would make CWAN suitable for growth investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CWAN had positive earnings in the past year.
In the past year CWAN had a positive cash flow from operations.
In the past 5 years CWAN reported 4 times negative net income.
CWAN had a positive operating cash flow in 4 of the past 5 years.
CWAN Yearly Net Income VS EBIT VS OCF VS FCFCWAN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

With an excellent Return On Assets value of 36.28%, CWAN belongs to the best of the industry, outperforming 99.29% of the companies in the same industry.
Looking at the Return On Equity, with a value of 42.09%, CWAN belongs to the top of the industry, outperforming 93.29% of the companies in the same industry.
CWAN has a Return On Invested Capital of 0.88%. This is in the better half of the industry: CWAN outperforms 65.72% of its industry peers.
Industry RankSector Rank
ROA 36.28%
ROE 42.09%
ROIC 0.88%
ROA(3y)10.25%
ROA(5y)-1.97%
ROE(3y)11.01%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CWAN Yearly ROA, ROE, ROICCWAN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

1.3 Margins

With an excellent Profit Margin value of 93.93%, CWAN belongs to the best of the industry, outperforming 98.23% of the companies in the same industry.
CWAN's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 2.71%, CWAN is in the better half of the industry, outperforming 67.84% of the companies in the same industry.
CWAN's Operating Margin has declined in the last couple of years.
The Gross Margin of CWAN (72.78%) is better than 62.90% of its industry peers.
CWAN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.71%
PM (TTM) 93.93%
GM 72.78%
OM growth 3Y-37.9%
OM growth 5Y-35.42%
PM growth 3YN/A
PM growth 5Y82.95%
GM growth 3Y-0.14%
GM growth 5Y0.23%
CWAN Yearly Profit, Operating, Gross MarginsCWAN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CWAN is destroying value.
CWAN has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CWAN has more shares outstanding
The debt/assets ratio for CWAN has been reduced compared to a year ago.
CWAN Yearly Shares OutstandingCWAN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CWAN Yearly Total Debt VS Total AssetsCWAN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

CWAN has an Altman-Z score of 26.01. This indicates that CWAN is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 26.01, CWAN belongs to the top of the industry, outperforming 96.47% of the companies in the same industry.
The Debt to FCF ratio of CWAN is 0.66, which is an excellent value as it means it would take CWAN, only 0.66 years of fcf income to pay off all of its debts.
CWAN's Debt to FCF ratio of 0.66 is fine compared to the rest of the industry. CWAN outperforms 76.68% of its industry peers.
A Debt/Equity ratio of 0.04 indicates that CWAN is not too dependend on debt financing.
CWAN's Debt to Equity ratio of 0.04 is in line compared to the rest of the industry. CWAN outperforms 59.01% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.66
Altman-Z 26.01
ROIC/WACC0.08
WACC10.93%
CWAN Yearly LT Debt VS Equity VS FCFCWAN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 4.99 indicates that CWAN has no problem at all paying its short term obligations.
The Current ratio of CWAN (4.99) is better than 87.28% of its industry peers.
A Quick Ratio of 4.99 indicates that CWAN has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 4.99, CWAN belongs to the top of the industry, outperforming 87.28% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.99
Quick Ratio 4.99
CWAN Yearly Current Assets VS Current LiabilitesCWAN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

9

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 29.73% over the past year.
Measured over the past years, CWAN shows a very strong growth in Earnings Per Share. The EPS has been growing by 110.89% on average per year.
Looking at the last year, CWAN shows a very strong growth in Revenue. The Revenue has grown by 22.72%.
The Revenue has been growing by 21.88% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)29.73%
EPS 3YN/A
EPS 5Y110.89%
EPS Q2Q%30%
Revenue 1Y (TTM)22.72%
Revenue growth 3Y21.48%
Revenue growth 5Y21.88%
Sales Q2Q%23.51%

3.2 Future

CWAN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.77% yearly.
Based on estimates for the next years, CWAN will show a very strong growth in Revenue. The Revenue will grow by 35.58% on average per year.
EPS Next Y31.18%
EPS Next 2Y27.75%
EPS Next 3Y16.77%
EPS Next 5YN/A
Revenue Next Year62.48%
Revenue Next 2Y44.97%
Revenue Next 3Y35.58%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CWAN Yearly Revenue VS EstimatesCWAN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
CWAN Yearly EPS VS EstimatesCWAN Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6

3

4. Valuation

4.1 Price/Earnings Ratio

CWAN is valuated quite expensively with a Price/Earnings ratio of 48.56.
CWAN's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 26.60. CWAN is valued rather expensively when compared to this.
Based on the Price/Forward Earnings ratio of 31.74, the valuation of CWAN can be described as expensive.
62.54% of the companies in the same industry are more expensive than CWAN, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.43, CWAN is valued a bit more expensive.
Industry RankSector Rank
PE 48.56
Fwd PE 31.74
CWAN Price Earnings VS Forward Price EarningsCWAN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

CWAN's Enterprise Value to EBITDA ratio is in line with the industry average.
CWAN's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 95.61
EV/EBITDA 262.74
CWAN Per share dataCWAN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

CWAN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
CWAN has a very decent profitability rating, which may justify a higher PE ratio.
CWAN's earnings are expected to grow with 16.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.56
PEG (5Y)0.44
EPS Next 2Y27.75%
EPS Next 3Y16.77%

0

5. Dividend

5.1 Amount

CWAN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CLEARWATER ANALYTICS HDS-A

NYSE:CWAN (5/21/2025, 11:02:59 AM)

23.31

-0.35 (-1.48%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)07-28 2025-07-28/amc
Inst Owners101.59%
Inst Owner Change5.87%
Ins Owners0.89%
Ins Owner Change41.02%
Market Cap6.60B
Analysts84.71
Price Target35.25 (51.22%)
Short Float %4.07%
Short Ratio3.32
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.32%
Min EPS beat(2)7.3%
Max EPS beat(2)13.33%
EPS beat(4)3
Avg EPS beat(4)7.36%
Min EPS beat(4)-0.14%
Max EPS beat(4)13.33%
EPS beat(8)7
Avg EPS beat(8)12.67%
EPS beat(12)10
Avg EPS beat(12)9.77%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.59%
Min Revenue beat(2)0.11%
Max Revenue beat(2)3.06%
Revenue beat(4)3
Avg Revenue beat(4)0.64%
Min Revenue beat(4)-0.78%
Max Revenue beat(4)3.06%
Revenue beat(8)5
Avg Revenue beat(8)0.25%
Revenue beat(12)7
Avg Revenue beat(12)0.05%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.42%
PT rev (3m)2.64%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.31%
EPS NY rev (1m)8.01%
EPS NY rev (3m)9.4%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.71%
Revenue NY rev (1m)34.09%
Revenue NY rev (3m)35.73%
Valuation
Industry RankSector Rank
PE 48.56
Fwd PE 31.74
P/S 14.62
P/FCF 95.61
P/OCF 88.85
P/B 6.55
P/tB 7.29
EV/EBITDA 262.74
EPS(TTM)0.48
EY2.06%
EPS(NY)0.73
Fwd EY3.15%
FCF(TTM)0.24
FCFY1.05%
OCF(TTM)0.26
OCFY1.13%
SpS1.59
BVpS3.56
TBVpS3.2
PEG (NY)1.56
PEG (5Y)0.44
Profitability
Industry RankSector Rank
ROA 36.28%
ROE 42.09%
ROCE 1.12%
ROIC 0.88%
ROICexc 1.15%
ROICexgc 1.31%
OM 2.71%
PM (TTM) 93.93%
GM 72.78%
FCFM 15.29%
ROA(3y)10.25%
ROA(5y)-1.97%
ROE(3y)11.01%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-67.54%
ROICexcg growth 5Y-60.6%
ROICexc growth 3Y-68.91%
ROICexc growth 5Y-61.61%
OM growth 3Y-37.9%
OM growth 5Y-35.42%
PM growth 3YN/A
PM growth 5Y82.95%
GM growth 3Y-0.14%
GM growth 5Y0.23%
F-Score5
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.66
Debt/EBITDA 1.77
Cap/Depr 43.17%
Cap/Sales 1.16%
Interest Coverage 3.53
Cash Conversion 304.41%
Profit Quality 16.27%
Current Ratio 4.99
Quick Ratio 4.99
Altman-Z 26.01
F-Score5
WACC10.93%
ROIC/WACC0.08
Cap/Depr(3y)83.6%
Cap/Depr(5y)112.55%
Cap/Sales(3y)1.75%
Cap/Sales(5y)1.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.73%
EPS 3YN/A
EPS 5Y110.89%
EPS Q2Q%30%
EPS Next Y31.18%
EPS Next 2Y27.75%
EPS Next 3Y16.77%
EPS Next 5YN/A
Revenue 1Y (TTM)22.72%
Revenue growth 3Y21.48%
Revenue growth 5Y21.88%
Sales Q2Q%23.51%
Revenue Next Year62.48%
Revenue Next 2Y44.97%
Revenue Next 3Y35.58%
Revenue Next 5YN/A
EBIT growth 1Y173.04%
EBIT growth 3Y-24.56%
EBIT growth 5Y-21.29%
EBIT Next Year34.39%
EBIT Next 3Y28.15%
EBIT Next 5YN/A
FCF growth 1Y-12.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-12.15%
OCF growth 3Y180.71%
OCF growth 5YN/A